These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33558663)

  • 41. B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.
    Koyama Y; Morikawa T; Miyama Y; Miyakawa J; Kawai T; Kume H; Sawabe M; Ushiku T
    Pathol Res Pract; 2020 Dec; 216(12):153219. PubMed ID: 33049447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
    Zhao SG; Lehrer J; Chang SL; Das R; Erho N; Liu Y; Sjöström M; Den RB; Freedland SJ; Klein EA; Karnes RJ; Schaeffer EM; Xu M; Speers C; Nguyen PL; Ross AE; Chan JM; Cooperberg MR; Carroll PR; Davicioni E; Fong L; Spratt DE; Feng FY
    J Natl Cancer Inst; 2019 Mar; 111(3):301-310. PubMed ID: 30321406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.
    Aung PP; Parra ER; Barua S; Sui D; Ning J; Mino B; Ledesma DA; Curry JL; Nagarajan P; Torres-Cabala CA; Efstathiou E; Hoang AG; Wong MK; Wargo JA; Lazar AJ; Rao A; Prieto VG; Wistuba I; Tetzlaff MT
    Clin Cancer Res; 2019 Jun; 25(11):3455-3467. PubMed ID: 30808776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
    Cattrini C; Rubagotti A; Nuzzo PV; Zinoli L; Salvi S; Boccardo S; Perachino M; Cerbone L; Vallome G; Latocca MM; Zanardi E; Boccardo F
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1257-e1265. PubMed ID: 30170989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer.
    Nunes-Xavier CE; Emaldi M; Guldvik IJ; Ramberg H; Taskén KA; Mælandsmo GM; Fodstad Ø; Llarena R; Pulido R; López JI
    Pathol Res Pract; 2023 Jan; 241():154243. PubMed ID: 36481650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer.
    Scribner JA; Brown JG; Son T; Chiechi M; Li P; Sharma S; Li H; De Costa A; Li Y; Chen Y; Easton A; Yee-Toy NC; Chen FZ; Gorlatov S; Barat B; Huang L; Wolff CR; Hooley J; Hotaling TE; Gaynutdinov T; Ciccarone V; Tamura J; Koenig S; Moore PA; Bonvini E; Loo D
    Mol Cancer Ther; 2020 Nov; 19(11):2235-2244. PubMed ID: 32967924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of B7-H3 in tumors and its potential in clinical application.
    Feng R; Chen Y; Liu Y; Zhou Q; Zhang W
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108153. PubMed ID: 34678689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibronectin enhances tumor metastasis through B7-H3 in clear cell renal cell carcinoma.
    Xie J; Sun M; Zhang D; Chen C; Lin S; Zhang G
    FEBS Open Bio; 2021 Nov; 11(11):2977-2987. PubMed ID: 34431237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
    Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
    Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
    Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
    Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B7-H3/CD276: An Emerging Cancer Immunotherapy.
    Zhou WT; Jin WL
    Front Immunol; 2021; 12():701006. PubMed ID: 34349762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
    Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O
    Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma.
    Song P; Xu Y; Ye G
    Diagn Pathol; 2024 Jun; 19(1):77. PubMed ID: 38858715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
    Liang J; Liu Z; Pei T; Xiao Y; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Yin X; Chen N; Wei X; Lu Y; Zhu Y
    Dis Markers; 2020; 2020():5354825. PubMed ID: 31998416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study.
    Barry M; Dhillon PK; Stampfer MJ; Perner S; Ma J; Giovannucci E; Kurth T; Mucci LA; Rubin MA
    Prostate; 2012 Feb; 72(3):301-6. PubMed ID: 21713964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis.
    Dai W; Shen G; Qiu J; Zhao X; Gao Q
    Oncol Rep; 2014 Nov; 32(5):2086-92. PubMed ID: 25120098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma.
    Zhou Z; Luther N; Ibrahim GM; Hawkins C; Vibhakar R; Handler MH; Souweidane MM
    J Neurooncol; 2013 Feb; 111(3):257-64. PubMed ID: 23232807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B7 score and T cell infiltration stratify immune status in prostate cancer.
    Zhou Q; Li K; Lai Y; Yao K; Wang Q; Zhan X; Peng S; Cai W; Yao W; Zang X; Xu K; Huang J; Huang H
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34417325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A promising target for breast cancer: B7-H3.
    Jiang Y; Liu J; Chen L; Qian Z; Zhang Y
    BMC Cancer; 2024 Feb; 24(1):182. PubMed ID: 38326735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.